Ningbo Tianyi Medical Appliance (301097.SZ) has obtained the product registration certificate for "disposable blood dialysis tubing".
Tianyi Medical (301097.SZ) announced that the company recently received the "Medical Device... issued by the National Medical Products Administration.
Ningbo Tianyi Medical Appliance (301097.SZ) announced that the company has recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The product is named disposable blood dialysis tubing. This product is used as a blood channel for blood dialysis, blood filtration, and blood dialysis filtration mode treatment for patients with acute and chronic renal failure.
The acquisition of the new product registration certificate enriches the company's product line, meets the differentiated and diversified needs of different customers for blood purification products, consolidates the company's competitive advantage in the field of blood purification consumables, continuously enhances the comprehensive competitiveness and market share of the company's products, and will have a positive impact on the company's future operations.
Related Articles
HK Stock Market Move | PCB concept stocks plunge across the board, according to reports, customers such as Samsung and SK Hynix intend to demand lower prices from PCB manufacturers in the second half of the year.
HK Stock Market Move | DL Holdings GP (01709) rose by over 7%, with a year-on-year increase in net profit of 1.65 times. The dividend plan exceeded 1.6 billion Hong Kong dollars.
HK Stock Market Move | PEGBIO CO-B(02565) increased by more than 5%. The preliminary form of review for the adjustment of the national medical insurance directory after 26 years has passed for the Peptide injection solution.
HK Stock Market Move | PCB concept stocks plunge across the board, according to reports, customers such as Samsung and SK Hynix intend to demand lower prices from PCB manufacturers in the second half of the year.
HK Stock Market Move | DL Holdings GP (01709) rose by over 7%, with a year-on-year increase in net profit of 1.65 times. The dividend plan exceeded 1.6 billion Hong Kong dollars.
HK Stock Market Move | PEGBIO CO-B(02565) increased by more than 5%. The preliminary form of review for the adjustment of the national medical insurance directory after 26 years has passed for the Peptide injection solution.
RECOMMEND
